{
    "nctId": "NCT05928429",
    "briefTitle": "Effects of Cryotherapy on Taxane-Induced Neuropathy in Patients With Breast Cancer",
    "officialTitle": "Effects of Cryotherapy on Objective and Subjective Symptoms of Taxane-Induced Neuropathy in Patients With Early Breast Cancer: A National, Multicenter, Prospective, Randomized, Controlled Trial",
    "overallStatus": "RECRUITING",
    "conditions": "CIPN - Chemotherapy-Induced Peripheral Neuropathy, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "Incidence of peripheral neuropathy",
    "eligibilityCriteria": "Inclusion Criteria:\n\nKey inclusion criteria; Patients with early breast cancer scheduled to receive weekly paclitaxel (80mg/m2 for one hour) 9 or 12 doses, PS 0-1\n\nExclusion Criteria:\n\nPeripheral sensory/motor neuropathy, neuralgia or edema of the limb graded \\>=2 (CTCAE ver 5.0), Patient with Raynaud's symptoms; peripheral arterial ischemia; or any other reasons based on the primary physician's judgment.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}